tbuckley/cabot-search huggingface dataset:
Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study
Authors: Lawson Eng, Rinku Sutradhar, Yue Niu, Ning Liu, Ying Liu, Yosuf Kaliwal, Melanie L. Powis, Geoffrey Liu, Jeffrey M. Peppercorn, Philippe L. Bedard, Monika K. Krzyzanowska
Journal: Journal of Clinical Oncology (2023)

Antibiotic exposure before immune checkpoint inhibitor (ICI) treatment can negatively affect outcomes through alteration in the gut microbiome, but large-scale evaluations are lacking. We performed a population-level retrospective cohort study to evaluate the impact of antibiotic exposure before starting ICI on overall survival (OS).Patients with cancer, age 65 years or older, who initiated treatment with ICIs between June 2012 and October 2018 in Ontario, Canada, were identified using systemic therapy administration data. The cohort was deterministically linked to other health care databases to obtain covariates and antibiotic prescription claim data at both 1 year and 60 days before ICI therapy. Multivariable Cox models evaluated the association between exposure and OS.Among the 2,737 patients with cancer who received ICIs, 59% and 19% of patients received antibiotics 1 year and 60 days before ICI therapy, respectively. Median OS was 306 days. Any antibiotic exposure within 1 year before ICI was associated with worse OS (adjusted hazard ratio [aHR], 1.12; 95% CI, 1.12 to 1.23; P = .03). In antibiotic class analysis, exposure to fluoroquinolones within 1 year (aHR, 1.26; 95% CI, 1.13 to 1.40; P < .001) or 60 days before ICI (aHR, 1.20; 95% CI, 0.99 to 1.45; P = .06) was associated with worse OS, with a dose effect seen on the basis of total weeks of exposure over 1 year (aHR, 1.07 per week; 95% CI, 1.03 to 1.11; P < .001) and 60 days (aHR, 1.12 per week; 95% CI, 1.03 to 1.23; P = .01).In this population-level study, exposure to antibiotics and specifically fluoroquinolones before ICI therapy was observed to be associated with worse OS among older adults with cancer. Interventions aimed at altering the gut microbiome to boost immunogenicity may help improve outcomes for patients receiving ICIs with prior antibiotic exposure.
Oral anticoagulants and fecal immunochemical tests for hemoglobin: do they go together?
Authors: Ulrike Haug
Journal: Endoscopy (2023)

In many countries of the world, the fecal immunochemical test for hemoglobin (FIT) is the main pillar of colorectal cancer (CRC) screening programs. The age range targeted by these programs, typically ≥ 50 years, corresponds to the age range in which cardiovascular morbidities are increasingly prevalent. Given that CRC and cardiovascular disease share several risk factors, those with cardiovascular disease are an important target group of CRC screening. This includes patients treated with oral anticoagulants (OACs), which are indicated for the prevention and treatment of thromboembolic disease and the prevention of ischemic stroke in patients with atrial fibrillation. It is known for both types of OAC (i. e. vitamin K antagonists [VKAs] and direct oral anticoagulants [DOACs]) that they increase the risk of gastrointestinal (GI) bleeding.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
Authors: Michelle Petri, Ian N Bruce, Thomas Dörner, Yoshiya Tanaka, Eric F Morand, Kenneth C Kalunian, Mario H Cardiel, Maria E Silk, Christina L Dickson, Gabriella Meszaros, Lu Zhang, Bochao Jia, Youna Zhao, Conor J McVeigh, Marta Mosca
Journal: The Lancet (2023)
Corrigendum to “Long-term Follow-up of Detaenial Sigmoid Neobladder Reconstruction for Paediatric Patients with Bladder and Prostate Rhabdomyosarcoma: Technique and Results from a Single High-volume Centre” [Eur Urol 2022;82(5):543–550]
Authors: Peng Xu, Chunxiao Chen, Binshen Chen, Enguang Bi, Wei Du, Ning Jiang, Zhe Liu, Hekui Lan, Manming Cao, Yazhen Liu, Jingwen Huang, Haiyan Shen, Cunrong Liu, Chunxiao Liu, Abai Xu
Journal: European Urology (2023)
Dampening type 2 properties of group 2 innate lymphoid cells by a gammaherpesvirus infection reprograms alveolar macrophages
Authors: Pauline Loos, Jérôme Baiwir, Céline Maquet, Justine Javaux, Rémy Sandor, François Lallemand, Thomas Marichal, Bénédicte Machiels, Laurent Gillet
Journal: Science Immunology (2023)

Immunological dysregulation in asthma is associated with changes in exposure to microorganisms early in life. Gammaherpesviruses (γHVs), such as Epstein-Barr virus, are widespread human viruses that establish lifelong infection and profoundly shape host immunity. Using murid herpesvirus 4 (MuHV-4), a mouse γHV, we show that after infection, lung-resident and recruited group 2 innate lymphoid cells (ILC2s) exhibit a reduced ability to expand and produce type 2 cytokines in response to house dust mites, thereby contributing to protection against asthma. In contrast, MuHV-4 infection triggers GM-CSF production by those lung ILC2s, which orders the differentiation of monocytes (Mos) into alveolar macrophages (AMs) without promoting their type 2 functions. In the context of γHV infection, ILC2s are therefore essential cells within the pulmonary niche that imprint the tissue-specific identity of Mo-derived AMs and shape their function well beyond the initial acute infection.
pDC-like cells are pre-DC2 and require KLF4 to control homeostatic CD4 T cells
Authors: Patrick Fernandes Rodrigues, Athanasios Kouklas, Grozdan Cvijetic, Nicolas Bouladoux, Mladen Mitrovic, Jigar V. Desai, Djalma S. Lima-Junior, Michail S. Lionakis, Yasmine Belkaid, Robert Ivanek, Roxane Tussiwand
Journal: Science Immunology (2023)

Plasmacytoid dendritic cells (pDCs) have been shown to play an important role during immune responses, ranging from initial viral control through the production of type I interferons to antigen presentation. However, recent studies uncovered unexpected heterogeneity among pDCs. We identified a previously uncharacterized immune subset, referred to as pDC-like cells, that not only resembles pDCs but also shares conventional DC (cDC) features. We show that this subset is a circulating precursor distinct from common DC progenitors, with prominent cDC2 potential. Our findings from human CD2-iCre and CD300c-iCre lineage tracing mouse models suggest that a substantial fraction of cDC2s originates from pDC-like cells, which can therefore be referred to as pre-DC2. This precursor subset responds to homeostatic cytokines, such as macrophage colony stimulating factor, by expanding and differentiating into cDC2 that efficiently prime T helper 17 (T H 17) cells. Development of pre-DC2 into CX3CR1 + ESAM − cDC2b but not CX3CR1 − ESAM + cDC2a requires the transcription factor KLF4. Last, we show that, under homeostatic conditions, this developmental pathway regulates the immune threshold at barrier sites by controlling the pool of T H 17 cells within skin-draining lymph nodes.
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
Authors: Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred
Journal: Journal of Clinical Oncology (2023)

Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the traditional ligand-binding assay (LBA). The purpose of this study was to evaluate the ability of ER status determination by IHC, compared with LBA, to predict clinical outcome-especially response to adjuvant endocrine therapy-in a large number of patients with long-term clinical follow-up.
Sustained release of magnesium and zinc ions synergistically accelerates wound healing
Authors: Fan Yang, Yijia Xue, Feilong Wang, Danni Guo, Yunjiao He, Xiao Zhao, Fanyu Yan, Yuqian Xu, Dandan Xia, Yunsong Liu
Journal: Bioactive Materials (2023)

Skin wounds are a major medical challenge that threaten human health. Functional hydrogel dressings demonstrate great potential to promote wound healing. In this study, magnesium (Mg) and zinc (Zn) are introduced into methacrylate gelatin (GelMA) hydrogel via low-temperature magnetic stirring and photocuring, and their effects on skin wounds and the underlying mechanisms are investigated. Degradation testing confirmed that the GelMA/Mg/Zn hydrogel released magnesium ions (Mg2+) and zinc ions (Zn2+) in a sustained manner. The Mg2+ and Zn2+ not only enhanced the migration of human skin fibroblasts (HSFs) and human immortalized keratinocytes (HaCats), but also promoted the transformation of HSFs into myofibroblasts and accelerated the production and remodeling of extracellular matrix. Moreover, the GelMA/Mg/Zn hydrogel enhanced the healing of full-thickness skin defects in rats via accelerated collagen deposition, angiogenesis and skin wound re-epithelialization. We also identified the mechanisms through which GelMA/Mg/Zn hydrogel promoted wound healing: the Mg2+ promoted Zn2+ entry into HSFs and increased the concentration of Zn2+ in HSFs, which effectively induced HSFs to differentiate into myofibroblasts by activating the STAT3 signaling pathway. The synergistic effect of Mg2+ and Zn2+ promoted wound healing. In conclusion, our study provides a promising strategy for skin wounds regeneration.
PD.02.01 High Extracellular Vesicle TGF-β &amp; PD-L1 Predict Poor Outcomes in Patients With Non-small Cell Lung Cancer Undergoing Immune-Checkpoint Inhibitors
Authors: Diego De Miguel Perez, None Alessandro Russo, Luis Lara-Mejía, Marisol Arroyo-Hernández, Muthukumar Gunasekaran, Feliciano Barron, Andres Cardona, Christine Peterson, Rivka Colen, Aung Naing, Vincenzo Adamo, Oscar Arrieta, Christian Rolfo
Journal: Journal of Thoracic Oncology (2023)
PSP.02 Using DNA Next-Generation Sequencing in blood to Guide Therapy for Newly Diagnosed Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients
Authors: Luis E. Raez, None Kayla Brice, Jill Tsai, Katerine Dumais, Paola Izquierdo, Leylah Drusbosky, Delia Wietecha, Alejandro Lopez-Cohen, Hiba Dada, Herman Powery, Edgardo Santos
Journal: Journal of Thoracic Oncology (2023)
PP.08 Analysis of the Status of Tumor-Infiltrating Lymphocytes (TILS) In Patients With NSCLC
Authors: Eduardo Richardet, I. Magi, V. Peruchin, P. Perea, A. Tello, M. Molina, L. Acosta, M. Paradelo, M. Richardet
Journal: Journal of Thoracic Oncology (2023)
PP.04 EGFR Structure-Based Classification and Presence of Commutations in Peruvian Patients With Advanced Lung Cancer
Authors: Melanie Castro-Mollo, Marco Galvez-nino, Katia Roque Perez, Rossana Ruiz, Natalia Valdivieso, Ofelia Coanqui, Mivael Olivera-Hurtado de Mendoza, Luis Mas
Journal: Journal of Thoracic Oncology (2023)
PD.02.02 Lung TS: A New 6-Gene Signature for Prediction of Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Patients
Authors: Pedro De Marchi, Letícia Ferro Leal, Luciane Sussuchi da Silva, Eduardo Caetano Albino Silva, Augusto Obuti Saito, Vladmir C. Cordeiro de Lima, Cristina Aguado, Maria González-Cao, Miguel Angel Molina-Vila, Rui Manuel Reis
Journal: Journal of Thoracic Oncology (2023)
PP.21 Genomic Landscape of Admixed Non-small Cell Lung Cancer: A Series of Brazilian Single-Center
Authors: Letícia Ferro Leal, Rodrigo de Oliveira Cavagna, Ícaro Alves Pinto, Pedro De Marchi, Flávio Augusto Ferreira da Silva, Débora Sant’Anna, Lázaro Antônio Campanha Novaes, Aline Larissa Virginio da Silva, Wellington dos Santos, Eduardo Caetano Albino da Silva, Vinícius Duval da Silva, Adriane Feijó Evangelista, Rui Manuel Reis
Journal: Journal of Thoracic Oncology (2023)
PP.42 Phase 1 Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced NSCLC
Authors: Byoung Chul Cho, Grace K. Dy, Tae Min Kim, Debashis Sarker, Omid Hamid, Stephen K. Williamson, Sang-We Kim, Hatim Husain, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Anne Paccaly, Sheila Masinde, Israel Lowy, Laura Brennan, Giuseppe Gullo
Journal: Journal of Thoracic Oncology (2023)
PP.22 Mutational Profile of Never-Smoker Patients With Lung Adenocarcinoma From a Single-Center in Brazil
Authors: Rodrigo de Oliveira Cavagna, Beatriz Garbe Zaniolo, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, Iara Vidigal Santana, Eduardo Caetano Albino da Silva, Josiane Mourão Dias, Alexandre Arthur Jacinto, Rachid Eduardo Noleto da Nóbrega Oliveira, Letícia Ferro Leal, Rui Manuel Reis
Journal: Journal of Thoracic Oncology (2023)
PP.34 Impact of Cardiac Comorbidities on Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy
Authors: Jenna Marek, William Doyle, Jose Malavet, Allison Dumitriu Carcoana, Diep Nguyen, William West, Cole Fiedler, Kristie Labib, Lauren Ladehoff, Rahul Mhaskar, Carla Moodie, Joseph Garrett, Jenna Tew, Jobelle Baldonado, Jacques Fontaine, Eric Toloza
Journal: Journal of Thoracic Oncology (2023)
PP.20 Concordance of Actionable Mutations in Liquid Biopsies and Matched Tumor Tissue of Brazilian Non-small Cell Lung Cancer (NSCLC)
Authors: Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Icaro Alves Pinto, Natália Zampieri Pontes, Rodrigo Sampaio Chiarantano, Pedro De Marchi, Flavio Augusto Ferreira da Silva, Adriane Feijó Evangelista, Rui Manuel Reis, Letícia Ferro Leal
Journal: Journal of Thoracic Oncology (2023)
PP.02 Tyrosine Kinase Inhibitor (TKI) Real-World Use in Epidermal Growth Factor Receptor Mutated (EGFRm) Advanced Non-small Cell Lung Cancer (NSCLC) Patients
Authors: Jose Minatta, Jens Samol, Fedor Moiseenko, Ingel Demedts, Vadim Kozlov, Michael Mark, Senthil Rajappa, Doreen A. Kahangire, Mutsa Madondo, Tom Bailey, Hannah Wallis, Mustafa Erman, Mauro Zukin
Journal: Journal of Thoracic Oncology (2023)
PD.02.04 A Prognostic Value of 3 Gene Sets for Ever-Smokers With Non-small Cell Lung Cancer From Brazil
Authors: Isabella Lemuqui Tegami, Luciane Sussuchi da Silva, Rodrigo de Oliveira Cavagna, Maria Fernanda Santiago Gonçalves, Flávio Augusto Ferreira Silva, Eduardo Caetano Albino Silva, Vinicius Duval Silva, Pedro De Marchi, Rui Manuel Reis, Letícia Ferro Leal
Journal: Journal of Thoracic Oncology (2023)
PSP.01 Disruptive and Truncating TP53 Mutations Are Frequent in Lung Adenocarcinoma Patients With African Ancestry and Show Worse Prognosis
Authors: Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, Débora Sant'Anna, Eduardo Caetano Albino da Silva, Josiane Mourão Dias, Agusto Antoniazzi, Miguel Angel Molina-Vila, Letícia Ferro Leal, Rui Manuel Reis
Journal: Journal of Thoracic Oncology (2023)
PP.12 Access to Molecular Testing and Factors to Implement Targeted Therapy in a Brazilian Public Health Service
Authors: Luma Princess Schneider, Pedro Nazareth Aguiar, Claudia Vaz de Melo Setti, Jean Henri Maselli-Schoueri, Barbara de Souza Gutierres Aguiar, Auro del Giglio
Journal: Journal of Thoracic Oncology (2023)
PP.05 Access to Genomic Testing and Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Single-Institution Study
Authors: Berenice Freile, Diego Enrico, Florencia Tsou, Federico Waisberg, Andres Rodriguez, Teresa Pombo, Andrea Mendoza, Ruben Salanova, Matias Chacon, Carmen Sofía Pupareli, Claudio Martin
Journal: Journal of Thoracic Oncology (2023)
PSP.03 12-Gene Expression Signature: A Potential Key for Predicting Prognosis and Benefit to ACT for Resectable NSCLC Patients
Authors: Aléxia Siqueira, Maria Fernanda Santiago Gonçalves, Isabella Lemuqui Tegami, Keila Cristina Miranda, Ícaro Alves Pinto, Pedro De Marchi, Josiane Mourão Dias, Iara Vidigal Santana, Vinicius Duval da Silva, Sabrina Setembre Batah, Heloisa Acurcio Zimermam, Alexandre Todorovic Fabro, Shen Yin, Conceição Souto-Moura, Susana Guimarães, Fátima Carneiro, Cláudia Freitas, Helder Novais e Bastos, Ignacio Wistuba, Yang Xie, Luciane Sussuchi da Silva, Rui Manuel Reis, Letícia Ferro Leal
Journal: Journal of Thoracic Oncology (2023)
PD.01.04 Rate of Pathogenic Germline Variants Detected in ctDNA Among Patients With Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
Authors: Samuel Kareff, Leylah Drusbosky, Luis E. Raez, Federico Albrecht, Mike Cusnir, Edgardo Santos, Estelamari Rodriguez
Journal: Journal of Thoracic Oncology (2023)
PD.02.06 Intensified Chemo-Immuno-Radiotherapy With Durvalumab for Stage Iii NSCLCS: A Brazilian Single Arm Phase Ii Study - Pacific Brazil (LACOG 2218)
Authors: William Nassib William Junior, Gilberto Castro Junior, Danielli Matias, Livia Alvarenga, Luiz Araújo, Victor Braga Gondim Teixeira, Gustavo Dix Junqueira Pinto, Tércia Reis, Taiane F. Rebelatto, Rafaela Gomes de Jesus, Cassio Murilo Trovo Hidalgo Filho, Gustavo Werutsky
Journal: Journal of Thoracic Oncology (2023)
PD.01.03 Genomic Landscape of Primary-Resistance to Osimertinib among Hispanic Patients With EGFR-Mutant Non-Small-Cell Lung Cancer: Results of an Observational Longitudinal-Cohort Study
Authors: Diego Chamorro, Andres Cardona, July Rodriguez, Alejandro Ruiz-Patiño, Oscar Arrieta, Darwin Moreno-Perez, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, Dora Ardila, Lucia Viola, Gonzalo Recondo, Juan B. Blaquier, Claudio Martin, Luis E. Raez, Suraj Samtani, Camila Ordoñez-Reyes, Juan Esteban Garcia-Robledo, Luis Corrales, Carolina Sotelo, Luisa Ricaurte, Mauricio Cuello, Sergio Mejia, Elvira Jaller, Carlos Vargas, Alessandro Russo, Umberto Malapelle, Diego de Miguel Perez, Vladmir C. Cordeiro de Lima, Helano Freitas, Christian Rolfo, Rafael Rosell
Journal: Journal of Thoracic Oncology (2023)
PP.03 Gender Differences in Lung Cancer in Chile
Authors: Diego Carrillo, Alonso Erazo, Jose Peña, Maria Loreto Bravo, Mauricio Pinto, Pablo Muñoz, Pablo Zoroquiain, Jose Valbuena, Joaquin Hevia, Carolina Goic, Christian Robles, Maria Eliana Solovera, Patricio Salas, Felipe Bannura, Hector Galindo
Journal: Journal of Thoracic Oncology (2023)
PP.51 Cost-Effectiveness Study of Lung Cancer Screening in Uruguay (UY-LUNGS)
Authors: Virginia Rodriguez Sande, Pablo Palacio, Virginia Suaya, Martin Rodriguez Parodi, Alonzo Rodriguez, Diego Touya, Mariela González, Fabiana Izzi, Enrique Barrios, Gerardo Bruno, Marisa Fazzino
Journal: Journal of Thoracic Oncology (2023)
PP.36 Thoracoscopic Limited Resection in Lung Adenocarcinoma, 4 Years Disease-Free Survival
Authors: Emmanuel Peña Gomez Portugal, Emmanuel Hernández Arguello, Luis M.M. Solorzano Campos, Nayeli Itzel Escalante Quesada, J Arciniega Dominguez, Alma Solano Nieto
Journal: Journal of Thoracic Oncology (2023)
PP.32 Postoperative Serum Magnesium Levels and Outcomes Following Robotic-Assisted Pulmonary Lobectomy
Authors: William West, Lauren Ladehoff, Kristie Labib, Cole Fiedler, Carla Moodie, Joseph Garrett, Jenna Tew, Jobelle Baldonado, Jacques Fontaine, Eric Toloza
Journal: Journal of Thoracic Oncology (2023)
PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients
Authors: Sooyun Tavolacci, Philip C. Mack, Jorge E. Gomez, Nicholas Rohs, Ananda M. Rodilla, Diego De Miguel Perez, Juan Manuel Carreño, Chin-Yuan Hsu, Jazz Cagan, Christian Rolfo, Amy Moore, Rachel I. Brody, Jennifer C. King, David E. Gerber, Claudia I. Henschke, David F. Yankelevitz, John D. Minna, Paul Bunn, Adolfo García-Sastre, Florian Krammer, Yu Shyr, Fred R. Hirsch
Journal: Journal of Thoracic Oncology (2023)
PP.07 Preliminary Results of a Western Mexican Cohort of Metastatic NSCLC and frequency of ALK, EGFR and PD-L1
Authors: Mauricio de Jesús Mora Pineda, Gabriela Alhelí Moreno Jaramillo, María de Jesús Preciado Durán, Betsabé Haro Contreras, Aldo Antonio Alcaraz Wong, Linda Alejandra Alvarado Rodriguez, Monica Isabel Meneses Medina, Jorge H. Hernandez-Felix, Feliciano Barron Barron, Ignacio Mariscal Ramírez
Journal: Journal of Thoracic Oncology (2023)
PP.43 Retrospective Analysis of Serum Parameters in Patients Treated With Check-Point Inhibitors in 2AND Line for Advance Non-small-Cell Lung Cancer
Authors: Pablo Flores Paco, Alberto Moreno, Isidoro Barneto, Pedro Sanchez, Alicia Vargas, Geraldina Guevara, Maria Lopez-Herrero, Enrique Aranda
Journal: Journal of Thoracic Oncology (2023)
PP.50 Implementation of an Institutional Lung Cancer Screening Program Using Low-Dose Computed Tomography in Argentina
Authors: María Delfina Peralta Tanco, Diego Hernán Enrico, Lisandro Paganini, Martín Eduardo Fernández, Fernando Verra, Juan Manuel Lucchelli, Wulfson Gabriela, Diana Velasquez Ayuni, Adolfo Manuel Rosales, Moisés Rosenberg, Emiliano Alberto Navarro, Florencia Tsou, Carmen Sofía Pupareli, Astorino Walter Adrián, Ximena García, Matías Rodrigo Chacón, Claudio Marcelo Martín, José Luis Morero
Journal: Journal of Thoracic Oncology (2023)
PP.26 Immunoexpression of 4 Different PD-L1 Clones in NSCLC Cases, a Comparative Study From Northeastern Brazil
Authors: Laura Cardoso, Marclesson Alves, Samuel Ferreira, Taynara Xavier, Fabio Nasser, Juliana Cordeiro, Francisco Martins Neto, Fabio Tavora
Journal: Journal of Thoracic Oncology (2023)
PP.53 Lung Cancer in Peru: A Disease of Never Smokers
Authors: Rossana Ruiz, Katia Roque, Heberth Daniel Vallejos, Melanie Castro-Mollo, Marco Galvez-nino, Mivael Olivera, Natalia Valdivieso, Ofelia Coanqui, Luis Mas
Journal: Journal of Thoracic Oncology (2023)
Table of contents
Authors: Margaret Kreher, Margaret Noland, Sailesh Konda, Maria Longo, Rodrigo Valdes-Rodriguez, Dirk Elston, Steven Sloan, Lisa Fredeau, Delphine Courvoisier, Raphael Mehdi, Saskia Ingen-Housz-Oro, Emmanuel Mahe, Nathalie Costedoat-Chalumeau, Laurent Arnaud, Camille France, Alexis Mathian, Marie Jachiet, Zahir Amoura, Jean David Bouaziz, Franc ¸ois Chasset, Amanda Rosenthal, Shivani Reddy, Robert Cooper, Joanie Chung, Jing Zhang, Reina Haque, Christina Kim, Supriya Rastogi, Rebecca Thiede, Lauren Sadowsky, Tammy Hua, Akash Rastogi, Corinne Miller, Bethanee Schlosser, Deepthi Konda, Laxmisha Chandrashekar, Rahul Dhodapkar, Nachiappa Ganesh, Devinder Thappa, Christos Chalitsios, Andrea Georgiou, Emmanouil Bouras, Evangelos Evangelou, Dipender Gill, Kostas Tsilidis, Ioanna Tzoulaki, Wanjarus Roongpisuthipong, Rachel Christensen, Mckenzie Dirr, Noor Anvery, Amelia Geisler, Matthew Schaeffer, Abigail Waldman, Joaquin Brieva, Murad Alam, Lucien Rizzo, Liz Lin, Abdullah Aleisa, Genevieve Huang, Adriana Dornelles, Bichchau Nguyen, Kaushik Venkatesh, Vinod Nambudiri, Nabiha Islam, Ashley Gray, Abraham Korman, John Trinidad, Jessica Kaffenberger
Journal: Journal of the American Academy of Dermatology (2023)
PP.19 Methylation Profile of Non-Small Cell Lung Cancer of Brazilian Patients
Authors: Sheila Fernandes, Anna Luiza Vicente, Bruna Pereira Sorroche, Flavio Augusto Ferreira da Silva, Vincent Cahais, Eduardo Caetano Albino Pinto, Vinicius Duval da Silva, Pedro De Marchi, Zdenko Herceg, Akram Ghantous, Rui Manuel Reis, Letícia Ferro Leal
Journal: Journal of Thoracic Oncology (2023)
PD.02.03 Alterations in the Immune Profile of LUSC and LUAD Detected by a Neural Network May Reveal New Immunotherapy Targets
Authors: Iael Weissberg, Ana Laura Seneda, André Franco Pagnin, Mateus Barros-Filho, Vanessa das Graças Pereira de Souza, Wan Lan, Patricia Pintor Reis, Sandra Aparecida Drigo
Journal: Journal of Thoracic Oncology (2023)
PP.16 Evaluation of Pathogenicity and in Silico Analysis of HERC2 Variants in Non-Small Cell Lung Cancer
Authors: Bruna Duarte, Rodrigo Cavagna, Aline Silva, Eduardo Silva, Adriane Feijó, Vinícius Duval, Wellington Santos, Flávio Silva, Pedro De Marchi, Rui Manuel Reis, Renato Oliveira, Letícia Ferro Leal
Journal: Journal of Thoracic Oncology (2023)
PP.44 Immune-Checkpoint Inhibitors: Biomarkers to Predict Response to Immunotherapy in Non-small Cell Lung Cancer Patients
Authors: Katiane Tostes, Bruna Pereira Sorroche, Nathália de Carvalho Rodrigues, Tauana Christina Dias, Joyce Alessandra Lima, Flávio Augusto Ferreira da Silva, Pedro Rafael Martins de Marchi, Céline Marques Pinheiro, Letícia Ferro Leal, Lidia Maria Rebolho Batista Arantes
Journal: Journal of Thoracic Oncology (2023)
PP.27 Clinical Outcomes of Stage III Non-small Cell Lung Cancer Patients Treated With Radical Radiotherapy in a Institution in Brazil
Authors: Denize Bodnar, Mariana Campos Bomfim, Mario Henrique Furlanetto Miranda, Alana Beatriz Tomazelli Visentainer, Raquel Mireski, Carolina Dutra, Rafael Balsini Barreto
Journal: Journal of Thoracic Oncology (2023)